Effect of preoperative angiotensin-converting enzyme inhibitor on the outcome of coronary artery bypass graft surgery
Authors:
- 30 July 2014
- journal article
- review article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 47 (5) , 788-795
Abstract
The safety of the preoperative administration of angiotensin-converting enzyme inhibitors (ACEIs) in patients undergoing coronary artery bypass grafting (CABG) surgery is still uncertain. This systematic review thus evaluated the effect of preoperative ACEIs on the clinical outcomes in patients undergoing CABG surgery. We searched PubMed, the Cochrane Library and the Web of Science for randomized control trials or observational studies that compared the use of ACEIs with that of placebos before isolated CABG. Thirteen studies (3 randomized control trials and 10 observational studies) that included 31 390 patients met the eligibility criteria. Preoperative ACEI treatment increased the risk of hypotension [risk ratio (RR) = 2.36, 95% confidence interval (CI) 1.11–5.02, P = 0.03], postoperative myocardial infarction (RR = 1.14, 95% CI 1.02–1.27, P = 0.02) and postoperative renal dysfunction (RR = 1.26, 95% CI 1.00–1.60, P = 0.05) in patients undergoing on-pump CABG, but had no significant impact on the risk of postoperative atrial fibrillation (RR = 0.79, 95% CI 0.37–1.71, P = 0.56) or postoperative stroke (RR = 1.17, 95% CI 0.74–1.85, P = 0.50), and did not influence the early mortality (RR = 1.21, 95% CI 0.95–1.54, P = 0.12) in patients undergoing on-pump CABG. Preoperative use of ACEIs increased the risk of several postoperative complications in patients undergoing CABG. Further randomized studies are needed to more clearly elucidate the risks and benefits of ACEI therapy before CABG.Keywords
This publication has 38 references indexed in Scilit:
- Outcomes of Preoperative Angiotensin-Converting Enzyme Inhibitor Therapy in Patients Undergoing Isolated Coronary Artery Bypass GraftingThe American Journal of Cardiology, 2012
- Transcatheter Valve TechnologyJACC, 2011
- Demographic determinants and effect of pre-operative angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the occurrence of atrial fibrillation after CABG surgeryBMC Cardiovascular Disorders, 2010
- Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgeryJournal of Cardiovascular Medicine, 2008
- Preoperative Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Is Associated with Increased Risk for Acute Kidney Injury after Cardiovascular SurgeryClinical Journal of the American Society of Nephrology, 2008
- Renin-angiotensin system and strokeNeurological Sciences, 2008
- Angiotensin-Converting Enzyme Inhibition Alters the Fibrinolytic Response to Cardiopulmonary BypassCirculation, 2003
- Tissue Angiotensin and Pathobiology of Vascular DiseaseHypertension, 2001
- Effects of quinapril on clinical outcome after coronary artery bypass grafting (the QUO VADIS study)The American Journal of Cardiology, 2001
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996